Management of Resistant Hypertension in Patients with Obstructive Sleep Apnea

Primary Treatment Approach

The American Academy of Sleep Medicine recommends initiating positive airway pressure (PAP) therapy in all patients with OSA and resistant hypertension, as this combination demonstrates clinically significant blood pressure reductions, particularly for nocturnal measurements 1, 2, 3
PAP therapy produces clinically significant blood pressure reductions in patients with resistant hypertension and OSA, with meta-analyses showing the largest effects on nocturnal blood pressure measurements 1, 2, 3
The American Academy of Sleep Medicine provides a conditional recommendation for PAP use specifically in adults with OSA and comorbid hypertension, based on moderate quality evidence demonstrating blood pressure reduction across all measurement periods (nocturnal, daytime, and 24-hour) 1, 2, 3

The American Academy of Sleep Medicine strongly recommends starting PAP therapy using either auto-adjusting PAP (APAP) at home or in-laboratory CPAP titration 4
Add heated humidification to the PAP device to reduce side effects including dry mouth/throat, nasal congestion, and other upper airway symptoms that may impair adherence 4
Use nasal or intranasal mask interfaces over oronasal masks when possible to maximize patient comfort and adherence 4

Ensure the patient is on at least three antihypertensive agents of different classes including a diuretic before confirming resistant hypertension, per ACC/AHA guidelines 5, 6
Target blood pressure should be <130/80 mmHg in patients with hypertension and comorbid conditions 5

Implement educational interventions at PAP initiation (strongly recommended), focusing on OSA consequences, PAP therapy mechanics, and potential benefits 1, 4
Consider behavioral interventions, troubleshooting support, and telemonitoring during the initial PAP therapy period to maximize adherence 4
The ACC/AHA guidelines note that CPAP effectiveness to reduce blood pressure is not well established (Class IIb, Level B-R recommendation), reflecting that studies show only small effects (2-3 mmHg reductions) dependent on compliance and OSA severity 6